Topsuper Med, Inc.

Topsuper Med, Inc. specializes in haemorrhoid ligation sets, which are used in surgical procedures to treat haemorrhoids by banding or ligating them. These devices are specifically designed for minimally invasive interventions to alleviate symptoms and promote healing.

Topsuper Med, Inc. is headquartered in the United States. The company’s location is relevant for understanding its regulatory framework and compliance with US medical device standards.

Topsuper Med, Inc.’s haemorrhoid ligation sets fall under Class II classification in the US regulatory system. This classification is typically assigned to devices that pose moderate risk and require special controls to ensure safety and effectiveness beyond general controls.

Yes, Topsuper Med, Inc.’s devices are included in the FDA’s Unique Device Identifier (UDI) database. Listing in the UDI system ensures traceability and transparency in the supply chain, helping healthcare providers and regulators track devices throughout their lifecycle.

The Class II classification for Topsuper Med, Inc.’s haemorrhoid ligation sets indicates that these devices undergo additional scrutiny beyond basic manufacturing controls. This classification ensures that the devices meet specific performance standards and safety requirements, reducing risks associated with their use in medical procedures.